Round It Up For Lymphoma Campaign Launched
Family Video, the largest privately-owned movie and game rentailer in the United States, is teaming up with the Lymphoma Research Foundation (LRF) for a campaign called 'Round it Up For Lymphoma.'
In this cause campaign, customers of Family Video will have the opportunity to support blood cancer research by rounding up their purchases to the nearest dollar. A full one hundred percent of the proceeds raised through Round It Up for Lymphoma will be used to fund research projects spearheaded by the LRF.
Said Family Video President Keith Hoogland, "This horrible disease has had an effect on our employees and their children, and we are going to do something about it!”
People can learn more about the campaign by visiting either www.familyvideo.com or www.lymphoma.org.
Source: Family Video
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
